Brief: Chinook Therapeutics Announces Update On Non-Renal Legacy Programs

Chinook Therapeutics

05/04/2021 13:18

April 5 (Reuters) - Chinook Therapeutics Inc  KDNY.O :
    * CHINOOK THERAPEUTICS ANNOUNCES UPDATE ON NON-RENAL LEGACY
PROGRAMS FROM ADURO BIOTECH MERGER
    * CHINOOK THERAPEUTICS INC - ANNOUNCED A TRANSACTION WITH
VAN HERK
INVESTMENTS
    * CHINOOK THERAPEUTICS INC - CHINOOK WILL OWN APPROXIMATELY
40
PERCENT OF SAIROPA AFTER FIRST TRANCHE OF FINANCING FROM VAN
HERK
    * CHINOOK THERAPEUTICS INC - HAVE ONE SEAT ON SAIROPA'S
BOARD OF
DIRECTORS.
    * CHINOOK THERAPEUTICS - CHINOOK ASSUMED ADURO'S
COLLABORATION AND
LICENSE AGREEMENTS WITH NOVARTIS, ELI LILLY
    * CHINOOK THERAPEUTICS INC - NOVARTIS RECENTLY NOTIFIED
CHINOOK
THAT IT HAS DISCONTINUED DEVELOPMENT OF FINAL STING PATHWAY
ACTIVATION PROGRAM

Source text for Eikon:  ID:nGNXc31TL 
Further company coverage:  KDNY.O 

 ((Reuters.Briefs@thomsonreuters.com;))